Page 115 - Haematologica June

Leukemia initiating cells in ALL
17. Shapiro HM. Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y. Cytometry. 1981;2(3):143-150.
18. Wilpshaar J, Falkenburg JH, Tong X, et al. Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood. 2000;96(6):2100-2107.
19. Darzynkiewicz Z, Juan G, Srour EF. Differential staining of DNA and RNA. Curr Protoc Cytom. 2004;Chapter 7:Unit 7.3.
20. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells. 1997;15 (Suppl 1):199-203; discussion 204-197.
21. Borowitz MJ, Shuster JJ, Civin CI, et al. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1990;8(8):1389-1398.
22. Pui CH, Hancock ML, Head DR, et al. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood. 1993;82(3):889-894.
23. Darzynkiewicz Z, Sharpless T, Staiano- Coico L, Melamed MR. Subcompartments of the G1 phase of cell cycle detected by flow cytometry. Proc Natl Acad Sci USA. 1980;77(11):6696-6699.
24. Darzynkiewicz Z, Traganos F, Melamed MR. New cell cycle compartments identi- fied by multiparameter flow cytometry. Cytometry. 1980;1(2):98-108.
25. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell molecular signature. Science. 2002;298 (5593):601-604.
26. Georgantas RW 3rd, Tanadve V, Malehorn M, et al. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res. 2004;64(13):4434-4441.
27. Gal H, Amariglio N, Trakhtenbrot L, et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia. 2006;20(12):2147-2154.
28. Jaatinen T, Hemmoranta H, Hautaniemi S, et al. Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells. 2006;24(3):631-641.
29. Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 2010;304(24):2706-2715.
30. Ito K, Hirao A, Arai F, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med. 2006;12(4):446-451.
31. Lagadinou ED, Sach A, Callahan K, et al. BCL-2 inhibition targets oxidative phospho- rylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12(3):329-341.
32. Romero-Moya D, Bueno C, Montes R, et al. Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function. Haematologica. 2013;98(7):1022-1029.
33. Ito K, Hirao A, Arai F, et al. Regulation of oxidative stress by ATM is required for self- renewal of haematopoietic stem cells. Nature. 2004;431(7011):997-1002.
34. Giambra V, Jenkins CR, Wang H, et al. NOTCH1 promotes T cell leukemia-initiat- ing activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species. Nat Med. 2012;18(11):1693-1698.
35. Fleming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional het- erogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol. 1993;122(4):897-902.
36. Morrison SJ, Weissman IL. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phe- notype. Immunity. 1994;1(8):661-673.
37. Gothot A, Pyatt R, McMahel J, Rice S, Srour EF. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood. 1997;90(11):4384-4393.
38. Gothot A, van der Loo JC, Clapp DW, Srour EF. Cell cycle-related changes in repopulat- ing capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 1998;92(8):2641-2649.
39. Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to pro- liferate in vitro lose engraftment potential
during their S/G(2)/M transit and do not
reenter G(0). Blood. 2000;96(13):4185-4193. 40. Ebinger S, Ozdemir EZ, Ziegenhain C, et al. Characterization of rare, dormant, and ther- apy-resistant cells in acute lymphoblastic
leukemia. Cancer Cell. 2016;30(6):849-862. 41. Greaves M. Cancer stem cells renew their
impact. Nat Med. 2011;17(9):1046-1048.
42. Morisot S, Wayne AS, Bohana-Kashtan O, et al. High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias. Leukemia.
2010;24(11):1859-1866.
43. Cox CV, Evely RS, Oakhill A, Pamphilon
DH, Goulden NJ, Blair A. Characterization of acute lymphoblastic leukemia progenitor cells. Blood. 2004;104(9):2919-2925.
44. Castor A, Nilsson L, Astrand-Grundstrom I, et al. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblas- tic leukemia. Nat Med. 2005;11(6):630-637.
45. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. mTOR con- trols cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukary- otic translation initiation factor 4E. Mol Cell Biol. 2004;24(1):200-216.
46. Gao N, Flynn DC, Zhang Z, et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/ p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol. 2004;287(2): C281-291.
47. Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell. 2007;129(6):1081-1095.
48. Churchman ML, Evans K, Richmond J, et al. Synergism of FAK and tyrosine kinase inhi- bition in Ph+ B-ALL. JCI. 2016;1(4):
49. Morrison SJ, Spradling AC. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell. 2008;132 (4):598-611.
50. Golan K, Wellendorf A, Takihara Y, et al. Mitochondria transfer from hematopoietic stem and progenitor cells to Pdgfr +/Sca-1- /CD48dim BM stromal cells via CX43 gap junctions and AMPK signaling inversely reg- ulate ROS generation in both cell popula- tions. Blood. 2016;128(22):5
haematologica | 2018; 103(6)
1017